Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-023372

PRESIDENT AND CEO sold 15,625 shares at an average $37.50 ($585,934)

  • PRESIDENT AND CEO acquired 15,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-09-11 Option exercise 10b5-1 +9,274 $2.90 $26,865 317,246 D: show line 1 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-09-11 Sale 10b5-1 −9,274 $37.31 $346,023 307,972 D: show line 2 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-09-11 Option exercise 10b5-1 +6,351 $2.90 $18,398 314,323 D: show line 3 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-09-11 Sale 10b5-1 −6,351 $37.78 $239,911 307,972 D: show line 4 in the form
Open-market sales · 15,625 sh · avg $37.50 · $585,934

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-09-11 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,625 827,337 D: show line 5 in the form
Loading xslF345X05/form4-09132024_080943.xml…